Unicycive Therapeutics, Inc.

Erasca Inc. and Imago BioSciences, Inc. raised the most money out of the five biopharmaceutical companies that launched initial public offerings during the first half of July, and their stocks were

Initial public offerings by biopharmaceutical companies are back on an above-average track after eight firms went public in the US during the week of 14 to 18 June, raising $1.46bn combined, including

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. GSK Becomes Surface Oncology’s Latest B

Unicycive Therapeutics was started by a single person, went public through an IPO in 2021, and four years later is preparing to continue its track record of proving skeptics wrong by independently lau